Book contents
- Cambridge Handbook of Pain Medicine
- Cambridge Handbook of Pain Medicine
- Copyright page
- Contents
- Contributors
- Pain Handbook Introduction
- Part I Introduction to Pain: Pain Signaling Pathways
- Part II Common Categories of Pharmacologic Medications to Treat Chronic Pain
- Chapter 4 Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- Chapter 5 Acetaminophen
- Chapter 6 Topicals
- Chapter 7 Muscle Relaxants
- Chapter 8 Opioids
- Chapter 9 Antineuropathic Medications
- Chapter 10 Cannabinoids
- Part III Chronic Pain Conditions Head and Neck
- Part IV Spine
- Part V Extremities
- Part VI Misc
- Part VII Adjunctive Therapy
- Index
- References
Chapter 6 - Topicals
Topical: Lidocaine, Capsaicin, Diclofenac
from Part II - Common Categories of Pharmacologic Medications to Treat Chronic Pain
Published online by Cambridge University Press: 01 December 2023
- Cambridge Handbook of Pain Medicine
- Cambridge Handbook of Pain Medicine
- Copyright page
- Contents
- Contributors
- Pain Handbook Introduction
- Part I Introduction to Pain: Pain Signaling Pathways
- Part II Common Categories of Pharmacologic Medications to Treat Chronic Pain
- Chapter 4 Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- Chapter 5 Acetaminophen
- Chapter 6 Topicals
- Chapter 7 Muscle Relaxants
- Chapter 8 Opioids
- Chapter 9 Antineuropathic Medications
- Chapter 10 Cannabinoids
- Part III Chronic Pain Conditions Head and Neck
- Part IV Spine
- Part V Extremities
- Part VI Misc
- Part VII Adjunctive Therapy
- Index
- References
Summary
Oral medication has been the mainstay of therapy; however, the use of topical formulation for chronic pain can reduce serious systemic side effects caused by oral medications. Topical administration of medication via patches, gels, creams, ointments, and solutions can provide local anesthesia and bypass major organ system. Lidocaine is an amide-type local anesthetic agent stabilizing the neuronal membranes by inhibiting the ionic fluxes required for initiation and conduction of impulses. Capsaicin is a selective agonist for TRPV1 receptor expressed in afferent neuronal C fibers and Ad fibers resulting in loss of receptor functionality causing impaired local nociception.Diclofenac works via inhibition of prostaglandin synthesis by blocking COX-1 and COX-2.
- Type
- Chapter
- Information
- Cambridge Handbook of Pain Medicine , pp. 49 - 52Publisher: Cambridge University PressPrint publication year: 2023